
Syd Labs, Inc.于 2010 年初創立于美國波士頓,采用重組技術生產有活性的蛋白質,包括重組抗體、重組抗原、重組酶、重組細胞因子以及其它重組蛋白,努力提高蛋白產量和活性、降低成本和價格、盡量避免使用動物作為生產工具。
悉得實驗室(Syd Labs, 簡稱"悉得”)強烈呼吁珍愛生命、減少使用動物生產抗體!
?
悉得(Syd Labs)重點推薦
|
Anti-mouse antibodies?(in vivo) |
體內實驗級重組抗小鼠靶點抗體 |
|
Isotype control antibodies |
同型對照抗體 |
|
Research grade?biosimilars |
科研級生物類似藥 |
|
Anti-human antibodies?(in vivo) |
體內實驗級重組抗人靶點抗體 |
?
體內實驗級重組抗小鼠靶點抗體
|
貨號 |
產品名稱 |
規格 |
|
PA007162.r2a |
Anti-mouse?PD-1?(clone?RMP1-14.1),?rIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007163.r2a |
Anti-mouse?PD-1?(clone?29F.1A12.1),?rIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007164.r2b |
Anti-mouse?PD-L1?(clone?10F.9G2.1),?rIgG2b |
1?mg;?5?mg;?25?mg |
|
PA007162.m2aLA |
Anti-mouse?PD-1?(clone?RMP1-14.1),?mIgG2a?LALAPG |
1?mg;?5?mg;?25?mg |
|
PA007162.m2cLA |
Anti-mouse?PD-1?(clone?RMP1-14.1),?mIgG2c?LALAPG |
1?mg;?5?mg;?25?mg |
|
PA007163.m2aLA |
Anti-mouse?PD-1?(clone?29F.1A12.1),?mIgG2a?LALAPG |
1?mg;?5?mg;?25?mg |
|
PA007163.m2cLA |
Anti-mouse?PD-1?(clone?29F.1A12.1),?mIgG2c?LALAPG |
1?mg;?5?mg;?25?mg |
|
PA007164.m2aLA |
Anti-mouse?PD-L1?(clone?10F.9G2.1),?mIgG2a?LALAPG |
1?mg;?5?mg;?25?mg |
|
PA007164.m2cLA |
Anti-mouse?PD-L1?(clone?10F.9G2.1),?mIgG2c?LALAPG |
1?mg;?5?mg;?25?mg |
|
PA007199.r2b |
Anti-mouse?CD3?(clone?17A2),?rIgG2b |
1?mg;?5?mg;?25?mg |
|
PA007198 |
Anti-mouse?CD3e?(clone?145-2C11),?mIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007201 |
Anti-mouse?CD3e?(clone?500A2),?mIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007200.r2b |
Anti-mouse?CD4?(clone?GK1.5),?rIgG2b |
1?mg;?5?mg;?25?mg |
|
PA007166.r2b |
Anti-Mouse?CD8a?(clone?YTS?169.4),?rIgG2b |
1?mg;?5?mg;?25?mg |
|
PA007167.r2b |
Anti-Mouse?CD8a?(clone?2.43),?rIgG2b |
1?mg;?5?mg;?25?mg |
|
PA007363.r2a |
Anti-mouse?CD19?(clone?1D3),?rIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007156.r1 |
Anti-mouse?CD25?(clone?PC61.5.3),?rIgG1?Lambda |
1?mg;?5?mg;?25?mg |
|
PA007274.r2a |
Anti-mouse?CD40?(clone?FGK4.5),?rIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007276.r2a |
Anti-mouse?CD137?(TNFRSF9/4-1BB)?(clone?3H3),?rIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007275.r1 |
Anti-mouse?CD137?(TNFRSF9/4-1BB)?(clone?LOB12?.3),?rIgG1 |
1?mg;?5?mg;?25?mg |
|
PA007168.r1 |
Anti-mouse?OX40?(clone?OX86),?rIgG1 |
1?mg;?5?mg;?25?mg |
|
PA007280.m2a |
Anti-mouse?TIG?IT?(clone?1F4),?mIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007279.m2a |
Anti-mouse?TIG?IT?(clone?10A7),?mIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007169.r2b |
Anti-mouse?GITR?(clone?DTA-1),?rIgG2a?Lambda |
1?mg;?5?mg;?25?mg |
?
同型對照抗體
|
貨號 |
產品名稱 |
規格 |
|
PA007125 |
Human?IgG1?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007128 |
Human?IgG4-S228P?Isotype?Control?Antibody |
1?mg;?5?mg;?25?mg |
|
PA007134 |
Human?IgG1-LALAPG?Isotype?Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007133 |
Human?IgG1-N297A?Isotype?Control?Antibody |
1?mg;?5?mg;?25?mg |
|
PA007132 |
Human?IgG1-D265A?Isotype?Control?Antibody |
1?mg;?5?mg;?25?mg |
|
PA007127 |
Human?IgG2?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007187 |
Chimeric?Human?IgG1?Isotype?Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007165.h?1 |
VHH-hIgG1?Fc?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007126 |
Mouse?IgG1?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007135 |
Mouse?IgG1-D265A?Isotype?Control?Antibody |
1?mg;?5?mg;?25?mg |
|
PA007129 |
Mouse?IgG2a?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007138 |
Mouse?IgG2a-LALAPG?Isotype?Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007130 |
Mouse?IgG2bIsotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA005171 |
Mouse?IgG2c?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007141 |
Mouse?IgG2c-LALAPG?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007161 |
Mouse?IgG3?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007142 |
Rat?IgG1?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007143 |
Rat?IgG2a?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007144 |
Rat?IgG2bIsotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007145 |
Rat?IgG2c?Isotype Control?Antibody |
1?mg;?5?mg;?25?mg |
|
PA007153.m1 |
Anti-HEL?(D1.3)?Mouse?IgG1?Isotype?Control?Antibody |
1?mg;?5?mg;?25?mg |
|
PA007154.m1 |
Anti-HEL?(HyHEL-10)?Mouse?IgG1?Isotype?Control?Antibody |
1?mg;?5?mg;?25?mg |
|
PA007155.m1 |
MOPC-21?Mouse?IgG1?Isotype?Control?Antibody |
1?mg;?5?mg;?25?mg |
|
PA007158.m1 |
Anti-DNP?Mouse?IgG1?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
PA007151.m1 |
B1-8?Mouse?IgG1?Isotype?Control?Antibody |
1?mg;?5?mg;?25?mg |
|
PA007165.m2a |
VHH-mIgG2a?Fc?Isotype Control Antibody |
1?mg;?5?mg;?25?mg |
|
BP4091 |
Human?IgG1?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4092 |
Human?IgG2?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4125 |
Human?IgG3?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4093 |
Human?IgG4?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4111 |
Mouse?IgG1?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4120 |
Mouse?IgG2a?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4121 |
Mouse?IgG2b?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4123 |
Mouse?IgG2c?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4124 |
Mouse?IgG3?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4126 |
Rat?IgG2a?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4127 |
Rat?IgG2b?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4122 |
Rabbit?IgG?Fc?Protein |
1?mg;?5?mg;?25?mg |
|
BP4119 |
Llama?IgG2b?Fc?Protein |
1?mg;?5?mg;?25?mg |
?
科研級生物類似藥
|
貨號 |
產品名稱 |
規格 |
|
C007P |
A?batacept?Biosimilar |
1?mg;?5?mg;?20?mg |
|
C003P |
Adalimumab?Biosimilar,?Human TNF alpha |
1?mg;?5?mg;?20?mg |
|
C013P |
Aflibercept?Biosimilar |
1?mg;?5?mg;?20?mg |
|
C040P |
Alemtuzumab?Biosimilar,?Human CD52 |
1?mg;?5?mg;?20?mg |
|
C024P |
Atezolizumab?Biosimilar,?Human?PD-L1 |
1?mg;?5?mg;?20?mg |
|
C008P |
Belatacept?Biosimilar |
1?mg;?5?mg;?20?mg |
|
C001P |
Bevacizumab?Biosimilar,?Human?VEGF |
1?mg;?5?mg;?20?mg |
|
C041P |
Briakinumab?Biosimilar,?Human?IL-12 /?IL-23 |
1?mg;?5?mg;?20?mg |
|
C002P |
Cetuximab?Biosimilar,?Human?EGFR |
1?mg;?5?mg;?20?mg |
|
C042P |
Clenoliximab?Biosimilar,?Human?CD4 |
1?mg;?5?mg;?20?mg |
|
C043P |
Daclizumab?Biosimilar,?Human?CD25 |
1?mg;?5?mg;?20?mg |
|
C030P |
Daratumumab?Biosimilar,?Human?CD38 |
1?mg;?5?mg;?20?mg |
|
C004P |
Denosumab?Biosimilar,?Human?RANKL |
1?mg;?5?mg;?20?mg |
|
C044P |
Drozitumab?Biosimilar,?Human TRAIL |
1?mg;?5?mg;?20?mg |
|
C022P |
Eculizumab?Biosimilar,?Human?C5 |
1?mg;?5?mg;?20?mg |
|
C045P |
Efalizumab?Biosimilar,?Human?CD11a |
1?mg;?5?mg;?20?mg |
|
C046P |
Epratuzumab?Biosimilar,?Human?CD22 |
1?mg;?5?mg;?20?mg |
|
C058P |
Ibalizumab?Biosimilar,?Human?CD4 |
1?mg;?5?mg;?20?mg |
|
C011P |
Infliximab?Biosimilar,?Human TNF?alpha |
1?mg;?5?mg;?20?mg |
|
C033P |
Minretumomab?Biosimilar,?Human TAG-72 |
1?mg;?5?mg;?20?mg |
|
C055P |
Natalizumab?Biosimilar,?Human?Integrin?alpha 4 |
1?mg;?5?mg;?20?mg |
|
C026P |
Nivolumab?Biosimilar,?Human?PD-1 |
1?mg;?5?mg;?20?mg |
|
C020P |
Omalizumab?Biosimilar,?Human?IgE |
1?mg;?5?mg;?20?mg |
|
C021P |
Palivizumab?Biosimilar,?RSV |
1?mg;?5?mg;?20?mg |
|
C012P |
Panitumumab?Biosimilar,?Human?EGFR/ErbB-1/HER1 |
1?mg;?5?mg;?20?mg |
|
C027P |
Pembrolizumab?Biosimilar,?Human?PD-1 |
1?mg;?5?mg;?20?mg |
|
C006P |
Pertuzumab?Biosimilar,?Human?HER2 |
1?mg;?5?mg;?20?mg |
|
C052P |
Polatuzumab?Biosimilar,?Human?CD79B |
1?mg;?5?mg;?20?mg |
|
C005P |
Ranibizumab?Biosimilar,?Human VEGF?Fragment?(Fab) |
1?mg;?5?mg;?20?mg |
|
C062P |
Relatlimab?Biosimilar,?Human?LAG-3 |
1?mg;?5?mg;?20?mg |
|
C010P |
Rituximab?Biosimilar,?Human?CD20 |
1?mg;?5?mg;?20?mg |
|
C071P |
Sacituzumab?Biosimilar,?Human Trop-2 |
1?mg;?5?mg;?20?mg |
|
C034P |
Secukinumab?Biosimilar,?Human?IL17A |
1?mg;?5?mg;?20?mg |
|
C110P |
Tanezumab?Biosimilar,?Human?NGF |
1?mg;?5?mg;?20?mg |
|
C056P |
Teplizumab?Biosimilar,?Human CD3e |
1?mg;?5?mg;?20?mg |
|
C032P |
Tocilizumab?Biosimilar,?Human?IL-6R |
1?mg;?5?mg;?20?mg |
|
C009P |
Trastuzumab?Biosimilar,?Human?HER2 |
1?mg;?5?mg;?20?mg |
|
C037P |
Tremelimumab?Biosimilar,?Human?CTLA-4 |
1?mg;?5?mg;?20?mg |
|
C038P |
Ustekinumab?Biosimilar,?Human?IL-12 /?IL-23 |
1?mg;?5?mg;?20?mg |
|
C070P |
Zolbetuximab?Biosimilar, Human?Claudin?18.2 |
1?mg;?5?mg;?20?mg |
?
體內實驗級重組抗人靶點抗體
|
貨號 |
產品名稱 |
規格 |
|
PA007157.m1 |
Anti-Human?HER2/ErbB-2/c-neu?(clone?muMab?4D5),?mIgG1 |
1?mg;?5?mg;?25?mg |
|
PA007196 |
Anti-human?CD3?(clone?SP34-2),?mIgG1 |
1?mg;?5?mg;?25?mg |
|
PA007197 |
Anti-human?CD3e?(clone?UCHT1),?mIgG1 |
1?mg;?5?mg;?25?mg |
|
PA007202.m2a |
Anti-human?CD3e?(clone?OKT3),?mIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007277.m1 |
Anti-human?CD16?(clone?3G8),?mIgG1 |
1?mg;?5?mg;?25?mg |
|
PA007271.m2a |
Anti-human?CD19?(clone?FMC63),?mIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007270.m1 |
Anti-human?CD19?(clone?SJ25C1),?mIgG1 |
1?mg;?5?mg;?25?mg |
|
PA007272.m2a |
Anti-human?CD19?(clone?B43),?mIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007273.m2a |
Anti-human?Siglec-2/CD22?(clone?NCI?m971),?mIgG2a |
1?mg;?5?mg;?25?mg |
|
PA007278.m1 |
Anti-human?CD56?(clone?N901),?mIgG1 |
1?mg;?5?mg;?25?mg |
?
標簽抗體
|
貨號 |
產品名稱 |
規格 |
|
PA000274.m1 |
Anti-DYKDDDDK-Tag?(clone?M2.1),?mIgG1 |
50?ug;?100?ug;?200?ug;?1?mg;?5?mg |
|
PA000002.m1 |
Anti-Myc-Tag?(clone?9E10),?mIgG1 |
50?ug;?100?ug;?200?ug;?1?mg;?5?mg |
|
PA007281.m2b |
Anti-HA-Tag?(clone?12CA5),?mIgG2b |
50?ug;?100?ug;?200?ug;?1?mg;?5?mg |
|
PA007282.m2b |
Anti-His-Tag?(clone?3D5),?mIgG2b |
50?ug;?100?ug;?200?ug;?1?mg;?5?mg |
D-熒光素鉀鹽
|
貨號 |
產品名稱 |
規格 |
|
MB000102-R70170 |
D-Luciferin?Potassium Salt |
1?g;?10?g |
悉得(Syd Labs)技術優勢
1 、 采用抗體藥物生產中常用的化學成分確定的培養基和 CHO 細胞,沒有來自 ?小鼠腹水和細胞培養基里 FBS 的抗體污染, ?沒有雜交瘤批次之間的不穩定性;
2 、 可以進行自由工程改造,包括切換 isotype 、Fc 突變、提升親和力和產量;
3 、 在同等內毒素標準下價格比國外同行低至 50% ,內毒素可低至 0.05 EU/mg (FDA 對臨床產品的質量要求),屬于當前科研抗體內毒素水平的天花板。
?
